leuvectin

leuvectin

Oncology An agent for treating metastatic melanoma, renal cell carcinoma, and sarcoma
References in periodicals archive ?
Vical's two lead product candidates, Allovectin-7 and Leuvectin, both involve direct injection of genetic material into tumors or surrounding tissue using lipids to facilitate delivery.
Leuvectin, which uses a lipid-DNA complex to stimulate an immune response against cancer cells, is in Phase II testing in patients with prostate cancer.
"We are currently conducting Phase II clinical trials of Leuvectin, our IL-2 product candidate, as a potential treatment for renal and prostate cancers," added Dr.